Headlines about LifePoint Health (NASDAQ:LPNT) have trended positive this week, Accern reports. The research firm scores the sentiment of press coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. LifePoint Health earned a news impact score of 0.44 on Accern’s scale. Accern also assigned news coverage about the company an impact score of 46.0016583450414 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.
LifePoint Health traded up $0.30, hitting $48.75, during trading on Tuesday, MarketBeat reports. 504 shares of the company’s stock traded hands, compared to its average volume of 690,271. The firm has a market cap of $1.87 billion, a price-to-earnings ratio of 13.46, a PEG ratio of 1.24 and a beta of 0.52. The company has a quick ratio of 1.55, a current ratio of 1.76 and a debt-to-equity ratio of 1.28. LifePoint Health has a 1 year low of $41.45 and a 1 year high of $66.05.
Get LifePoint Health alerts:
LifePoint Health (NASDAQ:LPNT) last announced its earnings results on Friday, May 4th. The company reported $1.22 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.13 by $0.09. The company had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.62 billion. LifePoint Health had a net margin of 0.48% and a return on equity of 6.56%. LifePoint Health’s revenue was down 1.7% compared to the same quarter last year. During the same period last year, the firm earned $1.07 earnings per share. analysts anticipate that LifePoint Health will post 4.3 EPS for the current fiscal year.
A number of equities analysts have recently commented on LPNT shares. Robert W. Baird reaffirmed a “buy” rating and set a $54.00 target price on shares of LifePoint Health in a research report on Tuesday, March 27th. Zacks Investment Research raised shares of LifePoint Health from a “hold” rating to a “buy” rating and set a $55.00 target price on the stock in a research report on Wednesday, July 4th. BidaskClub lowered shares of LifePoint Health from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, June 26th. Mizuho reissued a “hold” rating and set a $51.00 price objective on shares of LifePoint Health in a report on Thursday, March 22nd. Finally, SunTrust Banks reissued a “hold” rating and set a $58.00 price objective on shares of LifePoint Health in a report on Monday, May 7th. Two analysts have rated the stock with a sell rating, eleven have issued a hold rating and seven have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus target price of $53.67.
About LifePoint Health
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in the United States. Its hospitals provide a range of medical and surgical services, such as general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation, and pediatric, as well as specialized services, including open-heart surgery, skilled nursing, psychiatric care, and neuro-surgery.